Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8258268 Dual variable domain immunoglobulin and uses thereof

Patent 8258268 was granted and assigned to Abbott on September, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Tariq Ghayur0

Richard W. Dixon0

Chengbin Wu0

Jochen G. Salfeld0

Date of Patent

September 4, 2012

Patent Application Number

12459624

Date Filed

July 2, 2009

Patent Citations Received

US Patent 12129294 Methods of treatment of diseases in which IL-13 activity is detrimental using anti-IL-13 antibodies

0

US Patent 12065491 Anti-TREM1 antibodies and related methods

0

US Patent 12077594 IL2RG binding molecules and methods of use

0

US Patent 12077783 AAV-mediated delivery of antibodies to the inner ear

0

US Patent 12091468 Therapeutic antibodies that bind to the serine protease domain of MASP-2 and uses thereof

0

US Patent 12115191 Methods of treating age-related and inflammatory diseases

0

US Patent 12122826 Methods of treatment of diseases in which IL-13 activity is detrimental using anti-IL-13 antibodies

0

US Patent 12122839 IFNGR binding synthetic cytokines and methods of use

0

...

Patent Primary Examiner

Patent abstract

The present invention relates to engineered multivalent and multispecific binding proteins, methods of making, and specifically to their uses in the prevention and/or treatment of acute and chronic inflammatory and other diseases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8258268 Dual variable domain immunoglobulin and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool